Thank you for asking me to clarify.
It would be $50 million for a multi-product sterile injectables facility. The area in which we lack capacity for making things is injectables. Those include most medications used for critical reasons, and for $50 million we could set up a facility. When I talked to the outfit out of the University of Alberta, their plan would be to actually sell these internationally as well so that they could sort of self-finance and self-fund and be sustainable.
Then there are certain things called precursors to drugs. That's another area in which we've had a lot of problems. China seems to have a stranglehold on making these precursors. You often hear about generic drugs being made in India and all over the place, but actually 70% of the precursors to those are made in China. If we were able to spend another $50 million once, we could also set that up and actually have complete sovereignty.